- Home
- OCEA vs OMIC Comparison
OCEA vs OMIC Comparison
Compare OCEA & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEA
- OMIC
- Stock Information
- Founded
- OCEA 2019
- OMIC 2016
- Country
- OCEA United States
- OMIC United States
- Employees
- OCEA N/A
- OMIC N/A
- Industry
- OCEA Biotechnology: Pharmaceutical Preparations
- OMIC Medical/Dental Instruments
- Sector
- OCEA Health Care
- OMIC Health Care
- Exchange
- OCEA Nasdaq
- OMIC Nasdaq
- Market Cap
- OCEA 30.4M
- OMIC 34.9M
- IPO Year
- OCEA N/A
- OMIC 2021
- Fundamental
- Price
- OCEA $0.58
- OMIC $19.60
- Analyst Decision
- OCEA
- OMIC Hold
- Analyst Count
- OCEA 0
- OMIC 2
- Target Price
- OCEA N/A
- OMIC $10.75
- AVG Volume (30 Days)
- OCEA 42.2K
- OMIC 11.4K
- Earning Date
- OCEA 12-24-2024
- OMIC 11-12-2024
- Dividend Yield
- OCEA N/A
- OMIC N/A
- EPS Growth
- OCEA N/A
- OMIC N/A
- EPS
- OCEA N/A
- OMIC N/A
- Revenue
- OCEA N/A
- OMIC $2,667,000.00
- Revenue This Year
- OCEA N/A
- OMIC $3.98
- Revenue Next Year
- OCEA N/A
- OMIC $242.05
- P/E Ratio
- OCEA N/A
- OMIC N/A
- Revenue Growth
- OCEA N/A
- OMIC 2.77
- 52 Week Low
- OCEA $0.52
- OMIC $5.34
- 52 Week High
- OCEA $7.79
- OMIC $23.41
- Technical
- Relative Strength Index (RSI)
- OCEA 29.53
- OMIC 45.59
- Support Level
- OCEA $0.58
- OMIC $19.01
- Resistance Level
- OCEA $0.70
- OMIC $21.90
- Average True Range (ATR)
- OCEA 0.05
- OMIC 0.86
- MACD
- OCEA -0.00
- OMIC -0.34
- Stochastic Oscillator
- OCEA 1.21
- OMIC 21.81
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.